Quinine 3 (5 mmol) and triphenylphosphine (1.6 g, 6 mmol) were dissolved in anhydrous THF (25 mL), and the solution was cooled to 0 °C. Diethyl azodicarboxylate (1.0 g, 6 mmol) was subsequently added. To the resulting solution was added dropwise the solution of diphenyl phosphoryl azide (1.3 mL, 6 mmol) in anhydrous THF (10 mL) at 0 °C. The mixture was allowed to warm to ambient temperature. After 24 h, it was heated to 50°C when more triphenylphosphine (1.7 g, 6.5 mmol) was added, and the mixture was allowed to stir at 50 °C for additional 3 h. After that the solution was cooled to ambient temperature and H 2 O (0.5 mL) was added 4 . After the reaction mixture was stirred for another 10 h, 4-(Dimethylamino) acid chloride (1.098 g, 6 mmol) was added in one portion, then the reaction mixture was kept stirring at room temperature for 1 h. Solvents were removed in vacuo, and the residue was dissolved in CH 2 Cl 2 /10% aqueous HCl (25 mL/25 mL). The aqueous phase was separated and washed with CH 2 Cl 2 (25 mL × 4). It was subsequently basified with excess aqueous NH 3 , and extracted with CH 2 Cl 2 (25mL ×4). The combined organic layers were dried over Na 2 SO 4 , and concentrated in vacuo. Purification by flash chromatography using silica gel with EtOAc/hexane (v/v = 1/1) then EtOAc/CH 3 OH (v/v = 10/1) as an eluent yielded the corresponding amide containing product 11.
Representative procedure for allylation reaction.
To a 4 mL vial equipped with a stir bar was added the catalyst (0.03 mmol, 10 mol%). The vial was taken into glovebox, where anhydrous THF (1 mL), DIPEA (0.45 mmol, 1.5 equiv.) and allyltrichlorosilane (0.75 mmol, 2.5 equiv.) were added. The reaction mixture was taken outside the glovebox and the aldehyde (0.3 mmol) was added using a micropipette (open to air). The reaction mixture changed to bright red in color upon addition of aldehyde. The vial was then sealed and the reaction mixture was allowed to stir at ambient temperature for 24 h. The crude reaction mixture was quenched by pouring into a mixture of dichloromethane (5 mL) and saturated NaHCO 3 solution (5 mL). The resulting mixture was vigorously stirred for 1 h, and then extracted with dichloromethane (3 x 20 mL). The combined organic layer was washed with brine
(1 x 20 mL), dried over anhydrous Na 2 SO 4 and concentrated. Purification by silica gel chromatography yielded the recovered catalyst in quantitative yield and the desired product that was analyzed for purity by NMR and for enantioenrichment by chiral HPLC (Chiralcel OD-H, Chiralpark IC, AS-H or AD-H).
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Preliminary kinetic studies of the allylation reaction.
Determination of the dependence of the allylation reaction on catalyst:
To a 25 mL vial equipped with a stir bar was added the catalyst (0.036 mmol). The vial was taken into glovebox, where anhydrous THF (3 mL), DIPEA (0.45 mmol) and allyl trichlorosilane (2.5 mmol) were added. The reaction mixture was taken outside the glovebox, and the aldehyde (0.3 mmol) in 3 mL THF was added using a micropipette. The vial was then sealed and the reaction mixture was allowed to stir at ambient temperature. Real time conversion was determined by NMR (500MHz). . The absolute configuration of 2c was assigned by comparing its specific rotation with analogue. 98% ee. (HPLC condition: Chiralpark IC column, n-hexane/i-PrOH = 97:3, flow rate = 1.0 ml/min, wavelength = 254 nm, t R = 32.81 min for major isomer, t R = 41.08 min for minor isomer).
Catalyst 11
Catalyst 14 S10 (R)-1-((tert-butyldimethylsilyl)oxy) pent-4-en-2-ol (2d, Entry 4, Table 2 . The absolute configuration of 2d was assigned by comparing its specific rotation with that of the same compound reported in the literature. 6 The enantiomeric ratio of the compound was determined after converting to the corresponding 3,5-dinitrobenzate. 95% ee. (HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99.5:0.5, flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 32.81 min for major isomer, t R = 41.08 min for minor isomer).
Catalyst 14 S11 (R)-1-(1H-indol-3-yl) pent-4-en-2-ol (2e, Entry 5, . The absolute configuration of 2e was assigned by comparing its specific rotation with analogue. 96% ee. (HPLC condition: Chiralpark IC column, n-hexane/i-PrOH = 95:5 flow rate = 1 ml/min, wavelength = 254 nm, t R = 33.56 min for major isomer, t R = 37.40 min for minor isomer).
Catalyst 14 S12 (S)-hex-5-en-3-ol (2f, Entry 6, Table 2 Optical Rotation (from reaction with catalyst 11): [α] 25 D = -18 (0.5,CH 2 Cl 2 ). The absolute configuration of 2f was assigned by comparing its specific rotation with that of the same compound reported in the literature 6 . The enantiomeric ratio of the compound was determined after converting to the corresponding 3,5-dinitrobenzate. 96% ee. (HPLC condition: Chiralpark AD-H column, n-hexane/i-PrOH = 99:1, flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 14.34 min for major isomer, t R = 17.27 min for minor isomer).
Catalyst 14 S13 (S)-tridec-1-en-4-ol (2g, Entry 7, Table 2 . The absolute configuration of 2h was assigned by comparing its specific rotation with that of the same compound reported in the literature 6 . The enantiomeric ratio of the compound was determined after converting to the corresponding para-dimethylaminobenzate. 96% ee. (HPLC condition: Chiralpark AD-H column, n-hexane/i-PrOH = 99:1, flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 14.34 min for minor isomer, t R = 17.27 min for major isomer).
Catalyst 14 S14 (R)-1-phenylpent-4-en-2-ol (2h, Entry 8, Table 2 Optical Rotation (from reaction with catalyst 11): [α] 25 D = -3.2 (0.7, CH 2 Cl 2 ). The absolute configuration of 2i was assigned by comparing its specific rotation with that of the same compound reported in the literature 6 . 97% ee. (HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5 flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 14.31 min for major isomer, t R = 20.65 min for minor isomer).
Catalyst 14 S15 (S)-tetradeca-1,13-dien-4-ol (2i, Entry 9, Table 2 . The absolute configuration of 2j was assigned by comparing its specific rotation with analogue. The enantiomeric ratio of the compound was determined after converting to the corresponding 3,5-dinitrobenzate. 97% ee. (HPLC condition: Chiralpark AS-H column, nhexane/i-PrOH = 99:1 flow rate = 0.4 ml/min, wavelength = 254 nm, t R = 14.38 min for minor isomer, t R = 15.16 min for major isomer).
Catalyst 14 S16 (S, Z)-tetradeca-1, 11-dien-4-ol (2j, Entry 10, Table 2 The absolute configuration of 2n was assigned by comparing its specific rotation with analogue. The enantiomeric ratio of the compound was determined after converting to the corresponding para-dimethylaminobenzate. 96% de. (HPLC condition: Chiralpark AD-H column, n-hexane/i-PrOH = 99:1 flow rate = 1 ml/min, wavelength = 254 nm, t R = 16.66 min for minor isomer, t R = 19.043 min for major isomer). The absolute configuration of 16a was assigned by comparing its specific rotation with that of the same compound reported in the literature 8 . 97% ee. (HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1 flow rate = 1 ml/min, wavelength = 254 nm, t R = 17.51 min for minor isomer, t R = 25.082 min for major isomer). The absolute configuration of 16c was assigned by comparing its specific rotation with that of the same compound reported in the literature 6 . 96% ee. (HPLC condition: Chiralpark AS-H column, n-hexane/i-PrOH = 99:1 flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 17.89 min for minor isomer, t R = 21.42 min for major isomer). The absolute configuration of 16d was assigned by comparing its specific rotation with that of the same compound reported in the literature 6 . 95% ee. (HPLC condition: Chiralpark AS-H column, n-hexane/i-PrOH = 99:1 flow rate = 0.5 ml/min, wavelength = 254 nm, t R = 17.89 min for minor isomer, t R = 21.42 min for major isomer).
Catalyst 14
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